Status:
UNKNOWN
Revascularization StrategIes for ST Elevation Myocardial Infarction Trial
Lead Sponsor:
Unity Health Toronto
Conditions:
ST Elevation Myocardial Infarction
Coronary Stenting
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study is being conducted in patients with a major heart attack caused by a blocked artery undergoing Percutaneous Coronary Intervention (PCI) to open up the blockage. Up to 50% of people with an ...
Eligibility Criteria
Inclusion
- ST elevation myocardial infarction evidenced by new ST elevation at the J point in at least 2 contiguous leads of ≥ 2 mm (0.2mV) in men or ≥ 1.5mm (0.15mV) in women in leads V2-V3 and/or ≥ 1mm (0.1mV) in other contiguous chest leads or limb leads.
- MVD as evidenced by \> one significant (\>70% by visual assessment or FFR \< 0.80 for 50-70% stenosis) stenosis in the non-IRA \>2mm in diameter.
- Successful IRA-PCI with \<30% residual angiographic stenosis and TIMI III flow
- Written informed consent
Exclusion
- Age ≤ 18 years
- Prior coronary artery bypass graft (CABG) surgery
- Administration of thrombolytic therapy.
- Hemodynamic instability as evidenced by SBP\<90 mmHg, Killip class ≥3, and/or need for inotropes/vasopressors.
- Known renal insufficiency (estimated GFR \< 30 ml/min/1.73m2)
- Non-IRA stenosis is a chronic total occlusion (CTO)
- Plan by treating physician to treat non-IRA stenosis with coronary artery bypass surgery
Key Trial Info
Start Date :
September 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2021
Estimated Enrollment :
3520 Patients enrolled
Trial Details
Trial ID
NCT03263468
Start Date
September 1 2017
End Date
December 31 2021
Last Update
August 28 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.